Norbrook Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NORBROOK, and what generic and branded alternatives to NORBROOK drugs are available?
NORBROOK has two approved drugs.
Drugs and US Patents for Norbrook
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Norbrook | METHOTREXATE SODIUM | methotrexate sodium | INJECTABLE;INJECTION | 088648-001 | May 9, 1986 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Norbrook | METOCLOPRAMIDE HYDROCHLORIDE | metoclopramide hydrochloride | INJECTABLE;INJECTION | 070892-001 | Aug 26, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.